HomeNewsBusinessPNB Vesper gets DCGI nod to test its experimental drug on Covid-19 patients

PNB Vesper gets DCGI nod to test its experimental drug on Covid-19 patients

The company has filed the clinical trial application with the DCGI for the Phase 2 clinical trials, and the study will be completed in 60 days. The study will be conducted on 40 Covid-19 positive patients at BMJ Medical College, Pune.

Representative image

Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.

first published: Sep 11, 2020 03:20 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

PNB Vesper gets DCGI nod to test its experimental drug on Covid-19 patients

The company has filed the clinical trial application with the DCGI for the Phase 2 clinical trials, and the study will be completed in 60 days. The study will be conducted on 40 Covid-19 positive patients at BMJ Medical College, Pune.

Trending Topics

News

Markets

Personal Finance

Mutual Funds

Tools

Community

Network 18 Sites

Quick Links